Weems, Andrew D.
Welf, Erik S. http://orcid.org/0000-0002-5968-3323
Driscoll, Meghan K. http://orcid.org/0000-0001-7991-5614
Zhou, Felix Y.
Mazloom-Farsibaf, Hanieh
Chang, Bo-Jui http://orcid.org/0000-0002-5513-7106
Murali, Vasanth S. http://orcid.org/0000-0002-1782-7034
Gihana, Gabriel M. http://orcid.org/0000-0002-5443-4440
Weiss, Byron G. http://orcid.org/0000-0003-4396-5411
Chi, Joseph
Rajendran, Divya
Dean, Kevin M. http://orcid.org/0000-0003-0839-2320
Fiolka, Reto
Danuser, Gaudenz http://orcid.org/0000-0001-8583-2014
Article History
Received: 30 April 2021
Accepted: 25 January 2023
First Online: 1 March 2023
Competing interests
: The Board of Regents of the University of Texas System has filed for a patent (US patent 63/334,029, filed 22 April 2022) covering therapeutic targeting of septins and blebbing, which was based in part on data from this article. A.D.W., G.D., E.S.W. and M.K.D. are named as inventors. The authors declare no other competing interests.